Sneaking in an 8-K filing just before the cutoff time on Friday, investors who seek low float penny stocks will want to check out First Choice Healthcare Solutions, Inc. (FCHS). Thinly traded with an even thinner float, FCHS stock is sitting at less than half its 52 week high from a year ago while more than doubling their business in the first 6 months of 2013. Now that the Florida-based multi-specialty, healthcare services company has purchased, through 2 separate agreements, a 10% membership interest in a Florida distributor of leading edge multi-test medical diagnostic equipment, MedTech Diagnostics LLC, these next few trading sessions should be of great interest for anyone who likes money.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
FCHS Stock Quote
Market Cap: 11.43M
Last: 0.89 ▲ +0.15 (+20.27%)
Dollar Volume: $60,788
52Wk High: 2.45
52Wk Low: 0.051
Issued and Outstanding: 12,845,962
Chris Romandetti, CEO: 7,550,000
14-Day Rel Strength: 59.58%
1st Resistance Point: 0.9567
1st Support Level: 0.7867
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
The last 17 months have been very busy ones for First Choice Healthcare Solutions. In April, 2012, the Company merged into Medical Billing Assistance, Inc., changed its name, effectuated a 4-for-1 reverse split, and completed its acquisition of First Choice Medical Group of Brevard, LLC. Since April, 2012, Christian Charles Romandetti (aka Chris), President and CEO of First Choice Healthcare Services has put up some well-qualified numbers which should keep him in his seat without much of a dispute.
For the year ended December 31, 2012, First Choice booked revenues of $3,805,347 versus $1,304,757 from the prior year. The substantial increase, $2,500,590 or 192%, was thanks in part to the acquisition of First Choice Medical Group of Brevard, LLC. For the first 6 months of 2013, the Company booked net patient service revenue which nearly matched the increase from last year, $2,343,825. At that pace, $5 million in revenues for the year ended December 31, 2013 should be an easy accomplishment.
The trigger to why FCHS stock should be on the radar screens, is not only because it’s so thin, or because thy booked net income from operations during the 3 and 6 months ended June 30, 2013: $45,236 and $144,044, respectively. No, FCHS stock should be on your radar because, not only did they acquire a 10% interest in MedTech Diagnostics, but they also purchased, for 636,666 shares of restricted stock valued at $286,500, the rights and license to U.S. Patent Number 7,789,842, an adjustable arm sling with the ability to eliminate neck strain for patients needing to use a sling after surgery.
Since the patent belonged to Donald A. Bittar, CFO and member of the Company’s Board of Directors, the building of a super medical center where most people consider to be the 6th Burrough, Melbourne, Florida, FCHS stock is certainly on our radar screens. Some may be concerned that the Company’s modified conversion rate to $.45 per share on its $2MM line of credit with MTI Capital could mean dilution is coming, but, when you look closer at what’s happening, it shouldn’t be of much concern.
About FCHS Stock
First Choice Healthcare Solutions, Inc., through their wholly-owned subsidiaries: FCID Medical, Inc. and FCID Holdings, Inc., is an integrated, diversified, multi-specialty, healthcare services company focused on delivering state-of-the art, technologically advanced concierge physician and patient-centric services through the Company’s multi-specialty centers for excellence.
Last 5 Trading Sessions:
Healthcare penny stocks are always hot and one which is actually producing net income from operations with significant revenues like FCHS is sure to be a winner. Throw in the low share structure and thin level 2, and FCHS stock could see $2 before the first snow fall, maybe even before the first bye-week for the NFL.
Our Next Pick Is Coming Soon!
Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!